Breakpoints

113 Folgen

1. #93 – Global, Live Journal Club: Ceftobiprole for Complicated Staphylococcus aureus Bacteremia (ERADICATE Study)

   Vom: 23.2.2024
2. #92 – Antibiotic Alchemy: Metallo-Beta-Lactamases

   Vom: 2.2.2024
3. #91 – Teamwork Makes the Dream Work: Preparation Pearls for Stewardship and Microbiology Lab Accreditation Updates

   Vom: 19.1.2024
4. #90 – IDWeek 2023 Recap: Pipeline Agents and Clinical Trials That May Change Your Practice

   Vom: 5.1.2024
5. #89 – IDWeek 2023 Recap: Late Breaking Clinical Trials

   Vom: 22.12.2023
6. #88 – Dosing Consult: Can we BID farewell to Q8H Metronidazole?

   Vom: 1.12.2023
7. #87 – We Love T Cells: Updates in Cytomegalovirus

   Vom: 17.11.2023
8. #86 – The Robin to Your Batman: Ensuring Adequate Beta-lactamase Inhibitor Exposure to Restore Beta-lactam Activity

   Vom: 20.10.2023
9. #85 – Who You Gonna Call? Mythbusters! Antibiotic Myths for Infectious Diseases Clinicians

   Vom: 15.9.2023
10. #84 – Antimicrobial Stewardship and Disaster Medicine: Perspectives from Ukraine

    Vom: 18.8.2023
11. #83 – Dosing Consult: Sulfamethoxazole/trimethoprim

    Vom: 21.7.2023
12. #82 – ID Literature Year in Review (LIVE from MAD-ID)

    Vom: 23.6.2023
13. #81 – Making the Right Choice Easy: Antimicrobial Stewardship in the Emergency Department

    Vom: 16.6.2023
14. #80 – Weighting on a Miracle: Understanding Unknowns of Dosing Children and Adults with Obesity

    Vom: 2.6.2023
15. #79 – HAP & VAP: Let’s Clear the Air

    Vom: 26.5.2023
16. #78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?

    Vom: 28.4.2023
17. #77 – Breakpoints Talks Breakpoints: Non-fermenters

    Vom: 21.4.2023
18. #76 – Breakpoints Talks Breakpoints: Fluoroquinolones

    Vom: 14.4.2023
19. #75 – Breakpoints Talks Breakpoints: Aminoglycosides

    Vom: 7.4.2023
20. #74 – Breakpoints Talks Breakpoints: Piperacillin/tazobactam

    Vom: 31.3.2023